scispace - formally typeset
P

Peter A. Humphrey

Researcher at Yale University

Publications -  318
Citations -  28378

Peter A. Humphrey is an academic researcher from Yale University. The author has contributed to research in topics: Prostate & Prostate cancer. The author has an hindex of 76, co-authored 311 publications receiving 24811 citations. Previous affiliations of Peter A. Humphrey include Washington University in St. Louis & University of New Mexico.

Papers
More filters
Journal ArticleDOI

The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.

TL;DR: The basis for a new grading system was proposed in 2013 by one of the authors and accepted by the World Health Organization for the 2016 edition of Pathology and Genetics: Tumours of the Urinary System and Male Genital Organs.
Journal ArticleDOI

The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours.

TL;DR: This review summarizes the most significant differences between the newly published classification of urogenital tumours and the prior version for renal, penile, and testicular tumours.
Journal ArticleDOI

The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours.

TL;DR: Modifications to the Gleason grading system are incorporated into the 2016 WHO section on grading of prostate cancer, and it is recommended that the percentage of pattern 4 should be reported for Gleason score 7.
Journal ArticleDOI

The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia

John R. Srigley, +134 more
TL;DR: The classification working group of the International Society of Urological Pathology consensus conference on renal neoplasia was in charge of making recommendations regarding additions and changes to the current World Health Organization Classification of Renal Tumors, with consensus that 5 entities should be recognized as new distinct epithelial tumors within the classification system.